IT8012595A0 - Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazione - Google Patents

Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazione

Info

Publication number
IT8012595A0
IT8012595A0 IT8012595A IT1259580A IT8012595A0 IT 8012595 A0 IT8012595 A0 IT 8012595A0 IT 8012595 A IT8012595 A IT 8012595A IT 1259580 A IT1259580 A IT 1259580A IT 8012595 A0 IT8012595 A0 IT 8012595A0
Authority
IT
Italy
Prior art keywords
spasmolytic
anesthetics
analgesic
manufacture
amino ether
Prior art date
Application number
IT8012595A
Other languages
English (en)
Other versions
IT1136190B (it
Inventor
Dieran Robert Torossian
Claude Paul Joseph Roux
Gilbert Gustave Aubard
Original Assignee
Synthese Soc Ind Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthese Soc Ind Prod filed Critical Synthese Soc Ind Prod
Publication of IT8012595A0 publication Critical patent/IT8012595A0/it
Application granted granted Critical
Publication of IT1136190B publication Critical patent/IT1136190B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
IT12595/80A 1979-07-11 1980-07-11 Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazione IT1136190B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7917986A FR2460919A1 (fr) 1979-07-11 1979-07-11 Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IT8012595A0 true IT8012595A0 (it) 1980-07-11
IT1136190B IT1136190B (it) 1986-08-27

Family

ID=9227765

Family Applications (1)

Application Number Title Priority Date Filing Date
IT12595/80A IT1136190B (it) 1979-07-11 1980-07-11 Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazione

Country Status (11)

Country Link
US (1) US4301163A (it)
JP (1) JPS5615250A (it)
BE (1) BE884212A (it)
CA (1) CA1148547A (it)
CH (1) CH644348A5 (it)
DE (1) DE3026201A1 (it)
ES (1) ES493092A0 (it)
FR (1) FR2460919A1 (it)
GB (1) GB2054588B (it)
IT (1) IT1136190B (it)
NL (1) NL190237C (it)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692469A (en) * 1982-09-07 1987-09-08 Ciba-Geigy Corporation Propylamine derivatives
EP0102929B1 (de) * 1982-09-07 1987-07-01 Ciba-Geigy Ag Propylamin-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
US4824868A (en) * 1982-09-07 1989-04-25 Ciba-Geigy Corporation Propylamine derivatives useful for the treatment of dementia
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
FR2643369B1 (fr) * 1989-02-20 1991-07-05 Jouveinal Sa La (+) 1-((3,4,5-trimethoxy) benzyloxymethyl)-1-phenyl-n,n-dimethyl-n-propylamine, son procede de preparation et son application en therapeutique
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
WO1993001160A1 (en) * 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001169A2 (en) * 1991-07-05 1993-01-21 Merck Sharp & Dohme Limited Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
ATE133658T1 (de) * 1991-07-10 1996-02-15 Merck Sharp & Dohme Aromatische verbindungen diese enthaltende pharmazeutische zusammensetzungen und ihre therapeutische verwendung
US5495047A (en) * 1991-07-10 1996-02-27 Merck, Sharp & Dohme (Ltd.) Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
US5328927A (en) * 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
GB9211193D0 (en) * 1992-05-27 1992-07-08 Merck Sharp & Dohme Therapeutic agents
WO1994003429A1 (en) * 1992-07-31 1994-02-17 Merck Sharp & Dohme Limited Substituted amines as tachykinin receptor antagonists
US5948820A (en) 1994-08-22 1999-09-07 Yoshitomi Pharmaceutical Industries, Ltd. Benzene compound and pharmaceutical use thereof
JP3870419B2 (ja) * 1994-08-22 2007-01-17 三菱ウェルファーマ株式会社 ベンゼン化合物およびその医薬としての用途
RU2330839C2 (ru) 2002-01-11 2008-08-10 Санкио Компани, Лимитед Производные аминоспиртов или производные фосфорных кислот и фармацевтические композиции, содержащие указанные производные
US6986901B2 (en) * 2002-07-15 2006-01-17 Warner-Lambert Company Llc Gastrointestinal compositions
WO2004006901A1 (en) * 2002-07-10 2004-01-22 Warner-Lambert Company Llc Gastrointestinal compositions comprising gaba derivatives
CA2491797A1 (en) * 2002-07-10 2004-01-22 Warner-Lambert Company Llc Gastrointestinal compositions
US20040010035A1 (en) * 2002-07-15 2004-01-15 Ciociola Arthur A. Gastrointestinal compositions
TWI355934B (en) 2004-02-24 2012-01-11 Sankyo Co Pharmaceutical composition for treatment or prophy
SE0400968D0 (sv) * 2004-04-14 2004-04-14 Astrazeneca Ab Aryl glycine ether derivatives and their use
US7879913B2 (en) * 2005-06-28 2011-02-01 Catholic Healthcare West Iptakalim hydrochloride for decreasing nicotine use
EP2024323B1 (en) * 2006-06-06 2013-03-27 Gicare Pharma Inc. Salts of trimebutine and n-desmethyl trimebutine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2649445A (en) * 1948-02-28 1953-08-18 Bristol Lab Chloracetic acid ester of diphenyl ethanols
ES251290A1 (es) * 1958-08-21 1960-04-01 Parke Davis & Co Un procedimiento para la producciën de alcohilaminas arilsustituidas
GB1119835A (en) * 1964-07-20 1968-07-17 Analyses Et De Rech S Biolog M Process for the preparation of basic ethers
US4194009A (en) * 1974-01-10 1980-03-18 Eli Lilly And Company Aryloxyphenylpropylamines for obtaining a psychotropic effect
US4207343A (en) * 1978-06-22 1980-06-10 Eli Lilly And Company 1-Phenyl-3-(substituted phenoxy)propylamines

Also Published As

Publication number Publication date
NL8003601A (nl) 1981-01-13
GB2054588A (en) 1981-02-18
BE884212A (fr) 1981-01-08
NL190237C (nl) 1993-12-16
DE3026201A1 (de) 1981-02-26
FR2460919A1 (fr) 1981-01-30
GB2054588B (en) 1983-06-29
US4301163B1 (it) 1990-01-23
FR2460919B1 (it) 1983-11-10
JPS5615250A (en) 1981-02-14
CA1148547A (en) 1983-06-21
IT1136190B (it) 1986-08-27
CH644348A5 (fr) 1984-07-31
US4301163A (en) 1981-11-17
ES8103020A1 (es) 1981-02-16
JPS6253504B2 (it) 1987-11-10
ES493092A0 (es) 1981-02-16
DE3026201C2 (it) 1990-11-08
NL190237B (nl) 1993-07-16

Similar Documents

Publication Publication Date Title
IT1136190B (it) Ossidi di ammino eteri utilizzabili particolarmente come anestetici analgesici e spasmolitici e loro metodo di fabbricazione
AR225301A1 (es) Procedimiento para preparar benzamidas nortropil-alquilicas
IT8049287A0 (it) Contenitore multistrato e metodo di fabbricazione dello stesso
SE7803535L (sv) Magnethuvud och metod for tillverkning derav
NL930051I1 (nl) Lokaal anesthetisch mengsel voor topicale toepassing en werkwijze ter bereiding daarvan
ES497663A0 (es) Metodo para fabricar un cuerpo ceramico
IT8349135A0 (it) Poliossialchileneteri di glicerina o di 1,2-propandiolo esterificati con acido grasso e/o acido isostearico, loro produzione e loro impiego come agenti addensanti o solubilizzanti
IT1065311B (it) Metodo di preparazione ed impiego come algicida di un polielettrolito polietilenico
AR219401A1 (es) Bobinas de nucleo de aire y procedimiento para fabricarlas
IT1193348B (it) Composizione farmaceutica a base di acido tiazolidin-4-carbossilico per il trattamento di malattie neoplastiche e metodi di preparazione
IT8048615A0 (it) Pirazinobenzodiazepine loro preparazione e loro impiego come medicamenti
IT1195309B (it) Composti ai-77 loro sali farmaceuticamente accettabile e procedimento per produrli
BR7904194A (pt) Processo para sintese concomitante de esteres de alcanol e de glicol vicinal
IT1126509B (it) Benzimidi ad attivita' anestetica locale e antiaritmica,processo per la loro preparazione e composizioni farmaceutiche che le contengono
IT1171411B (it) Amminoglucosidi ammidinati procentimento per loro preparazione e loro impiego come medicamenti
IT1070015B (it) Eteramine secondarie e processo per la loro preparazione
BR7606350A (pt) Transformador aperfeicoado e processo para fabrica-lo
ATA495176A (de) Verfahren zur herstellung neuer homophthalimide und ihrer salze
SE7811794L (sv) Magnethuvud och metod for framstellning derav
PL197115A1 (pl) Sposob wytwarzania przedzy rdzeniowej i urzadzenie do wytwarzania przedzy rdzeniowej
ES535791A0 (es) Procedimiento para preparar un nucleo magnetico de material ferromagnetico de caracter oxido.
AT376203B (de) Verfahren zur herstellung des neuen n-(1-methyl-2-pyrrolidinylmethyl)-2,3-dimethoxy 5- methylsulfamoylbenzamids, seiner salze, oxide und optisch aktiven isomeren
ZW17581A1 (en) N-(1-allyl-2-pyrrolidinyl-methoxy 4-amino 5-methysulfamoyl benzamide its method of preparation and its use as a medicament
FR2332979A1 (fr) Halogenures d'acides sulfamiques et leur preparation
IT1193321B (it) Procedimento per la produzione contemporanea di combustibile per reattori e di combustibile diesel

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970729